Characterization of polymethylmethacrylate microspheres loaded with silver and doxycycline for dental materials applications
Source abstract
Abstract
Objectives The manufacturing of polymethylmethacrylate(PMMA) microspheres loaded with doxycycline(DOX) and/or silver sulfate(Ag2SO4) to be incorporated into glass ionomer cement(GIC). Methods PMMA microspheres were manufactured with Ag2SO4(1-5%) and/or DOX(5-15%). Particle size, encapsulation efficiency and drug release were measured by light microscope, ICP, and HPLC. Microspheres were added to a dental GIC(20%w/w). Drug release and DTS were investigated. Minimum inhibitory concentration and antibacterial effects of PMMA microspheres into GIC materials were tested. Results The median diameter of 50 µm was obtained for microspheres. DOX was encapsulated at an efficiency of 8.3% using a theoretical loading of 15%DOX + 5%Ag2SO4. The Ag2SO4 encapsulation efficiency was 0.63% using a theoretical loading of 5%AgSO4. All groups showed burst release within the first day and continued released up to 15 days, with 60-83% of DOX and approximately 30% of silver. For GIC, approximately 15% of DOX and 0.18% of silver were released in a 7-day period. Microbiological results showed an antimicrobial effect against S. mutans when the lead formulation of microspheres was added. The DTS was reduced by the inclusion of microspheres. Significance PMMA microspheres containing DOX and Ag2SO4 offer a sustained antimicrobial activity for dental applications and promising potential for the biomedical field.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Dental materials and restorations · Endodontics and Root Canal Treatments · Medical and Biological Ozone Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (66)
Show source-provided references
1. Global, regional, and national prevalence, incidence, and disability-adjusted life years for oral conditions for 195 countries, 1990-2015: a systematic analysis for the global burden of diseases, injuries, and risk factors10.1177/0022034517693566 ↗
2. Application of antibiotics/antimicrobial agents on dental caries
3. Global-, regional-, and country-level economic impacts of dental diseases in 201510.1177/0022034517750572 ↗
4. The relationship of oral health with general health and NCDs: a brief review10.1111/idj.12360 ↗
5. Income inequality and tooth loss in the United States10.1177/0022034511400081 ↗
6. An in vitro quantitative antibacterial analysis of amalgam and composite resins10.1016/j.jdent.2006.07.009 ↗
7. The Minamata Convention on Mercury: a first step toward protecting future generations10.1289/ehp.121-A304 ↗
8. Nanotechnology strategies for antibacterial and remineralizing composites and adhesives to tackle dental caries10.2217/nnm.14.191 ↗
9. Secondary caries and microleakage
10. Nanomaterials in preventive dentistry10.1038/nnano.2010.83 ↗
11. Silver nanoparticles in dental biomaterials
12. Clinical efficacy and the antimicrobial potential of silver formulations in arresting dental caries: a systematic review10.1186/s12903-020-01133-3 ↗
13. A review of the properties and applications of poly (methyl methacrylate) (PMMA)10.1080/15583724.2015.1031377 ↗
14. Rechargeable microbial anti-adhesive polymethyl methacrylate incorporating silver sulfadiazine-loaded mesoporous silica nanocarriers10.1016/j.dental.2017.07.009 ↗
15. Issues related to wind energy conversion systems10.1504/IJETP.2005.008397 ↗
16. Dental caries10.1016/S0140-6736(07)60031-2 ↗
17. Oral microbial biofilm models and their application to the testing of anticariogenic agents10.1016/j.jdent.2016.04.010 ↗
18. Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms10.3389/fcimb.2015.00010 ↗
19. Targeting: S. mutans biofilms: a perspective on preventing dental caries10.1039/C9MD00015A ↗
20. Are the mutans streptococci still considered relevant to understanding the microbial etiology of dental caries?10.1186/s12903-018-0595-2 ↗
21. Mechanical and biological characterization of resin-modified glass-ionomer cement containing doxycycline hyclate10.1016/j.archoralbio.2011.08.009 ↗
22. Zinc-inhibited MMP-mediated collagen degradation after different dentine demineralization procedures10.1159/000337315 ↗
23. Role of dentin MMPs in caries progression and bond stability10.1177/0022034514562833 ↗
24. Design of a multiple drug delivery system directed at periodontitis10.1016/j.biomaterials.2013.07.093 ↗
25. New intracanal formulations containing doxycycline or chlorhexidine against Enterococcus faecalis10.5005/jp-journals-10024-1488 ↗
26. Critical review in oral biology & medicine: the use of nanoparticles to control oral biofilm formation10.1177/0022034510377794 ↗
27. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver10.1016/j.ijantimicag.2009.01.017 ↗
28. Silver diamine fluoride: a successful anticarious solution with limits10.1177/0022034517740123 ↗
29. Randomized trial of silver nitrate with sodium fluoride for caries arrest
30. Selection of restorative materials for the atraumatic restorative treatment (ART) approach: a review10.1111/j.1754-4505.2001.tb00257.x ↗
31. Minimal intervention dentistry for managing dental caries - a review: report of a FDI task group10.1111/idj.12007 ↗
32. Review on fluoride-releasing restorative materials-fluoride release and uptake characteristics, antibacterial activity and influence on caries formation10.1016/j.dental.2006.01.022 ↗
33. Glass ionomer cements with milled, dry chlorhexidine hexametaphosphate filler particles to provide long-term antimicrobial properties with recharge capacity10.1016/j.dental.2018.09.003 ↗
34. The effects of heat treatment on selected properties of a conventional and a resin-modified glass ionomer cement10.1007/s10856-007-3270-8 ↗
35. Effects of prepolymerized particle size and polymerization kinetics on volumetric shrinkage of dental modeling resins
36. Toward dental caries: exploring nanoparticle-based platforms and calcium phosphate compounds for dental restorative materials
37. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold10.1016/j.nano.2008.04.005 ↗
38. Controlled-release and antibacterial studies of doxycycline-loaded poly(ε-caprolactone) microspheres10.1016/j.jscs.2011.11.004 ↗
39. Antibacterial silver-containing silica glass prepared by sol-gel method10.1016/S0142-9612(99)00201-X ↗
40. Study on the preparation and properties of silver-doped phosphate antibacterial glasses (Part I)10.1016/j.solidstatesciences.2011.02.004 ↗
41. The role of matrix metalloproteinases (MMPs) in human caries10.1177/154405910608500104 ↗
42. Toxicity of chlorhexidine on odontoblast-like cells10.1590/S1678-77572010000100010 ↗
43. Long-term antibacterial effects and physical properties of a chlorhexidine-containing glass ionomer cement10.1111/j.1708-8240.2008.00146.x ↗
44. Antibacterial activity of glass-ionomer cement containing antibiotics on caries lesion microorganisms
45. Antibacterial activity and physical properties of glass-ionomer cements containing antibiotics10.2341/08-30 ↗
46. The effect of antimicrobial additives on the properties of dental glass-ionomer cements: a review10.1080/23337931.2018.1539623 ↗
47. Antibacterial effects and physical properties of glass-ionomer cements containing chlorhexidine for the ART approach10.1016/j.dental.2005.08.003 ↗
48. Antibacterial properties and compressive strength of new one-step preparation silver nanoparticles in glass ionomer cements (NanoAg-GIC)10.1016/j.jdent.2017.12.003 ↗
49. Development of a novel antimicrobial-releasing glass ionomer cement functionalized with chlorhexidine hexametaphosphate nanoparticles10.1186/1477-3155-12-3 ↗
50. A critical review of lipid-based nanoparticles for taxane delivery10.1016/j.canlet.2012.07.006 ↗
51. Silver ion release from antimicrobial polyamide/silver composites10.1016/j.biomaterials.2004.05.030 ↗
52. An in vitro synergetic evaluation of the use of nisin and sodium fluoride or chlorhexidine against Streptococcus mutans10.1016/j.peptides.2011.09.002 ↗
53. Antibacterial activity of glass-ionomer cements, compomers and resin composites: relationship between acidity and material setting phase10.1111/j.1365-2842.2004.01300.x ↗
54. Antimicrobial effects of dental luting glass ionomer cements on streptococcus mutans
55. An in vitro assessment of the physical properties of manually- mixed and encapsulated glass-ionomer cements10.1038/s41405-020-0040-x ↗
56. Evaluation of antibacterial and remineralizing nanocomposite and adhesive in rat tooth cavity model10.1016/j.actbio.2014.02.033 ↗
57. Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm10.1128/AAC.00054-07 ↗
58. Bacterial counts in carious dentine under restorations: 2-year in vivo effects10.1159/000016506 ↗
59. In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles10.1016/j.ijpharm.2010.06.023 ↗
60. Chlorhexidine release from an experimental glass ionomer cement10.1016/j.biomaterials.2003.12.051 ↗
61. Antibacterial activity, surface roughness, flexural strength, and solubility of conventional luting cements containing chlorhexidine diacetate/cetrimide mixtures10.1016/S0022-3913(13)60349-2 ↗
62. Antibacterial activity, fluoride release, and physical properties of an antibiotic-modified glass ionomer cement
63. Compressive strength and setting time determination of glass-ionomer cements incorporated with cetylpyridinium chloride and benzalkonium chloride
64. Strength characteristics and marginal sealing ability of chlorhexidine-modified glass ionomer cement: an in vitro study10.4103/0970-4388.95580 ↗
65. Incorporation of chlorhexidine gluconate or diacetate into a glass-ionomer cement: porosity, surface roughness, and anti-biofilm activity
66. Epidemiology and etiology of denture stomatitis10.1111/j.1532-849X.2011.00698.x ↗